A Study of ARQ 197 in Combination With Erlotinib

Clinical trial NCT01251796 · COMPLETED

Trial details

NCT number: NCT01251796
Sponsor: Kyowa Kirin Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Recurrent Non-small-cell Lung Cancer

Start date: 2010-12-01
Primary completion: 2012-11-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.